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Previewswherein EGF-stimulated PAK activation
facilitates SRC-3D4 phosphorylation at
T56, resulting in EGFR binding. PAK-
mediated phosphorylation of SRC-3D4
at S659 and S676 promotes its binding
to the FERM domain of FAK. Interestingly,
EGF or modulation of SRC-3D4 expres-
sion did not affect FAK phosphorylation
at Y397, but SRC-3D4 knockdown was
associated with decreased FAK Y925
phosphorylation, c-Src activation, and
signaling to the ERK/mitogen-activated
protein (MAP) kinase. Phosphorylation of
FAK Y925 is mediated by c-Src and
promotes the binding of the Grb2 adaptor
protein to FAK, leading to ERK/MAP
kinase activation (Mitra and Schlaepfer,
2006). Although not directly tested, these
results imply that the SRC-3D4 linkage
enhances EGF-stimulated FAK activation
via binding to the FAK FERM domain,
leading to conformational FAK activation
and the enhanced formation of a FAK-
Src signaling complex (determined by
changes in FAK Y925 phosphorylation).
Although FAK Y925 is not essential for
normal fibroblast motility, this site is
required in promoting an angiogenic
switch in tumors (Mitra and Schlaepfer,
2006; Tomar et al., 2009). Interestingly,
when Long et al. (2010) injected MDA-
MB231 cells overexpressing SRC-3D4
(which show enhanced motility-invasion
in vitro associated with elevated FAK
Y925 phosphorylation) into mouse breast172 Developmental Cell 18, February 16, 201fat pads, these cells exhibit enhanced
lymph node and lung metastasis without
alterations in primary tumor growth.
Because increased levels of SRC-3D4
cells were found circulating in the blood,
Long et al. proposed that this may reflect
increased motility or extravasation of
tumor cells from primary tumor sites.
Overall, this study provides intriguing
results supporting a new signaling con-
nection for a cytoplasmically distributed,
alternate-spliced isoform of SRC-3.
Although this study provides valuable
steps forward in resolving some of the
mysteries surrounding the linkage
between EGFR and FAK, several ques-
tions remain. What are the SRC-3D4
binding sites on EGFR or FAK FERM,
and how does phosphorylation of SRC-
3D4 influence binding? Does SRC-3D4
link FAK to other receptors such as the
platelet-derived growth factor receptor
known to promote PAK activation and
cell motility? Because SRC-3D4 expres-
sion is generally low in noncancerous
cell types, do different mechanisms
promote FAK association with EGFR in
normal versus cancer cells? What is the
connection between tumor-associated
SRC-3D4 expression, FAK Y925 phos-
phorylation, and the invasive cell pheno-
type? Clearly, the identification of
SRC-3D4 as a bridging protein raises
many exciting new questions whose
answers are needed for understanding0 ª2010 Elsevier Inc.the molecular mechanisms initiating and
controlling cell movement.ACKNOWLEDGMENTS
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Alternative polyadenylation generates mRNAs with 30 untranscribed regions of different lengths, often
affecting transcript stability. Hornyik et al., in this issue ofDevelopmental Cell, and Liu et al. now demonstrate
a role for alternative polyadenylation in gene silencing and the regulation of flowering time in Arabidopsis
thaliana.Messenger RNA (mRNA) 30 end process-
ing defines the end of the transcript
through endonucleolytic cleavage of the
precursor transcript, provides aprotectivepolyadenylate tail, and enables subse-
quent termination of transcription by RNA
polymerase II. Just as alternative splicing
allows greater diversity of mRNA prod-ucts from a limited number of genes, in
animals and plants it is estimated that
>50% of genes have alternative polyade-
nylation (polyA) sites, the majority of
Figure 1. Antisense Alternative Polyadenylation Regulates Expression of FLC
(A) FPA and FCA promote selection of the class I polyA site (pA) of the antisense transcript that initiates
downstream of the FLC gene (red and pink arrows) by stimulating 30 end formation at that site. 30 end
processing at the class I polyA site recruits the histone demethylase, FLD, which induces transcriptionally
repressive histone modifications on internal nucleosomes (gray circles) that result in FLC silencing.
(B) Selection of class II polyA site (in the absence of FPA and FCA) causes nucleosomal rearrangements
around the FLC promoter. This facilitates activation of FLC, shown as recruitment of RNA polymerase II
(blue).
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Previewswhich result in 30 untranslated regions
(UTRs) of different lengths. The physiolog-
ical significance of alternative polyadeny-
lation was recently highlighted by the
observation that cancer cells frequently
utilize promoter-proximal polyA sites
preferentially, which results in the loss of
negative regulatory elements often found
in longer 30 UTRs and, consequently,
higher protein levels (Mayr and Bartel,
2009). Two recent studies now demon-
strate an intriguing role for 30 end process-
ing in the gene silencing that controls
flowering time in Arabidopsis thaliana
through the alternative polyadenylation
of an antisense transcript (Hornyik et al.,
2010; Liu et al., 2010).
Flowering time is regulated by the
expression of the FLC gene product, a
flowering repressor. Two RNA binding
proteins, FPA and FCA, act independently
to inhibit the expression of FLC, thereby
allowing flowering to take place. The
new studies demonstrate that both
factors regulate FLC expression through
polyA site selection—but in an unex-pected way. Hornyik and colleagues
(2010), reporting in this issue of Develop-
mental Cell, demonstrated that FPA
promotes the use of promoter-proximal
polyA sites over distal sites in the FPA
gene itself. Further indicative of a more
general role for FPA, plants expressing
mutant FPA fail to process transcripts of
the gene encoding ribosomal protein
S29c at its polyA site, leading to read-
through transcription (Hornyik et al.,
2010). Thus, it appears that FPA has an
important role in recognizing polyA sites.
Similarly, FCA promotes proximal polyA
site selection at its own gene (Quesada
et al., 2003), but neither FPA nor FCA are
likely to have a universal role in polyA site
selection, since FPA does not control
polyA site selection at FCA, or vice versa
(Hornyik et al., 2010). In a suppressor
mutagenesis screen designed to identify
factors that mediate the repressive effect
of FCA on FLC expression, Liu and
colleagues (2010), reporting in a recent
issue of Science, identified CstF64 and
CstF77, two evolutionarily conservedDevelopmental Cell 18,components of the cleavage stimulatory
factor (CstF) subcomplex of the cleavage
and polyadenylation machinery (Colgan
and Manley, 1997), thereby implicating
30 end formation in regulating FLC expres-
sion. One might expect, then, that FPA
and FCA inhibit FLC expression by regu-
lating its 30 end formation, possibly
through alternative polyadenylation. Sur-
prisingly, however, 30 end formation of
FLC is unaffected in plants expressing
mutant forms of FPA, FCA, CstF64, or
CstF77, all of which are defective in FLC
silencing (Hornyik et al., 2010; Liu et al.,
2010).
Unexpectedly, silencing of FLC expres-
sion by 30 end processing involves the
altered polyA site selection of an anti-
sense transcript. A promoter situated
downstream of the polyA site of FLC and
on the opposite strand generates anti-
sense transcripts that have alternative
polyA sites (Figure 1) (Liu et al., 2007;
Swiezewski et al., 2007). The polyA site
of class I antisense transcripts is situated
opposite the terminal intron of FLC,
whereas the polyA site of class II tran-
scripts is situated opposite the FLC
promoter. Hornyik and colleagues (2010)
demonstrated that FPA associates with
FLC chromatin downstream of the anti-
sense class I polyA site. Both groups
further provided evidence that FPA
promotes usage of the class I polyA site
over class II (Hornyik et al., 2010; Liu
et al., 2010). Meanwhile FCA, which
occupies the class I polyA site (Liu et al.,
2007), also promotes selection of the
class I polyA site over the class II site
(Hornyik et al., 2010; Liu et al., 2010).
There is a correlation, then, between
generation of the shorter antisense tran-
script, associated with class I polyA site,
and inhibition of sense FLC expression.
How does preferential selection of the
antisense class I polyA site facilitate
silencing of FLC? Although they work
through independent genetic pathways,
FLC silencing by both FPA and FCA
requires the activity of FLD, a dimethy-
lated histone H3 Lys 4 (H3K4me2) deme-
thylase that is homologous to human
LSD1 (Baurle and Dean, 2008; Liu et al.,
2007). Interestingly, CstF components
also require FLD to silence FLC (Liu
et al., 2010), implying that 30 end process-
ing at the class I polyA site affects FLC
expression through histone modifica-
tions. Taken together, it appears asFebruary 16, 2010 ª2010 Elsevier Inc. 173
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Previewsthough FPA and FCA converge near the
antisense class I polyA site to indepen-
dently facilitate 30 end formation, and
this action recruits the FLD demethylase
that catalyzes removal of the transcrip-
tionally active chromatin mark H3K4me2
in the body of the FLC gene, leading to
FLC silencing (Figure 1A). However, it
seems more than just coincidence that
in the absence of functional FPA or FCA,
a longer antisense transcript is generated
with a polyA site situated opposite the
promoter of the sense FLC product. As
Hornyik and colleagues point out, allow-
ing transcription to continue through the
class I polyA site and terminating near
the class II site could generate nucleo-
somal rearrangements that stimulate
activation of the FCL promoter on the
other strand (Figure 1B), a strategy used
in yeast to regulate expression of the
PHO5 gene (Uhler et al., 2007). As such,
alternative polyadenylation of the anti-
sense transcript can have an interesting
dual role in switching FLC from silenced
to expressed. By this model, selection of
the class I polyA site represses FLC ex-174 Developmental Cell 18, February 16, 201pression through targeted histone modifi-
cations mediated by 30 end formation,
while selection of the class II site stimu-
lates FLC expression by allowing anti-
sense transcription opposite the FLC
promoter (Figure 1).
Antisense transcription is well known
to regulate gene expression through tran-
scriptional interference, chromatin, DNA,
and nucleosomal modifications mediated
by transcription itself or through the
formation of RNA-DNA hybrids or
double-stranded RNA. The recent studies
discussed here now implicate 30 end pro-
cessingof antisense transcripts in control-
ling expression of sense genes, as well.
Genomic analyses indicate that antisense
transcription is prevalent in mammals.
Among antisense transcripts detected
within genes, a significant fraction are pol-
yadenylated (Lian et al., 2008), suggesting
that regulated 30 end formation of anti-
sense transcripts has the potential to
provide a significant new mechanism of
gene control, not only in signaling when
a plant may flower, but also more broadly
in animals as well as in plants.0 ª2010 Elsevier Inc.REFERENCES
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